Evaluate the Safety and Effectiveness of the enVista® One-Piece Hydrophobic Acrylic Trifocal Intraocular Lens
Public ClinicalTrials.gov record NCT03603600. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Multicenter, Randomized, Active-Controlled Clinical Study to Evaluate the Safety and Effectiveness of the enVista® One-Piece Hydrophobic Acrylic Trifocal Intraocular Lens in Subjects Undergoing Cataract Extraction
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of the study is to evaluate the safety and effectiveness of the enVista trifocal intraocular lens when implanted in the capsular bag.
Study identification
- NCT ID
- NCT03603600
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 501 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 22 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2018 (Actual)
- Primary completion
- May 4, 2023 (Actual)
- Completion
- May 4, 2023 (Actual)
- Last update posted
- Dec 24, 2024
2018 – 2023
United States locations
- U.S. sites
- 23
- U.S. states
- 14
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Bausch Site 108 | Fayetteville | Arkansas | 72703 | — |
| Bausch Site 113 | Garden Grove | California | 02843 | — |
| Bausch Site 120 | Northridge | California | 91325 | — |
| Bausch Site 115 | Redding | California | 96002 | — |
| Bausch Site 103 | Torrance | California | 90505 | — |
| Bausch Site 107 | Mt. Dora | Florida | 32757 | — |
| Bausch Site 117 | Lake Villa | Illinois | 60046 | — |
| Bausch Site 101 | Bloomington | Minnesota | 55420 | — |
| Bausch Site 119 | Birmingham | Mississippi | 49009 | — |
| Bausch Site 102 | St Louis | Missouri | 63131 | — |
| Bausch Site 124 | Omaha | Nebraska | 68137 | — |
| Bausch Site 118 | Las Vegas | Nevada | 89145 | — |
| Bausch Site 106 | Brecksville | Ohio | 44141 | — |
| Bausch Site 109 | Columbus | Ohio | 43215 | — |
| Bausch Site 116 | Pittsburgh | Pennsylvania | 16066 | — |
| Bausch Site 121 | Sioux Falls | South Dakota | 57108 | — |
| Bausch Site 112 | Memphis | Tennessee | 38119 | — |
| Bausch Site 110 | Nashville | Tennessee | 37205 | — |
| Bausch Site 104 | Cedar Park | Texas | 78613 | — |
| Bausch Site 105 | Dallas | Texas | 75243 | — |
| Bausch Site 111 | Houston | Texas | 77008 | — |
| Bausch Site 122 | San Antonio | Texas | 78215 | — |
| Bausch Site 123 | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03603600, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 24, 2024 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03603600 live on ClinicalTrials.gov.